Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer

Oncologist - United States
doi 10.1634/theoncologist.2009-0275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press


Related search